Candela
This article was originally published in The Gray Sheet
Executive Summary
Medical and cosmetic laser manufacturer cites disagreement over final price and financing terms in calling off a March proposed deal with Advanced Medical Alliance related to the sale of Candela's Boston and Scottsdale, Arizona skin care centers. "We worked long and hard to reach a definitive agreement with the potential purchaser, but we found that both price and financial terms were not going to be in the best interest of our shareholders," Candela President and CEO Gerard Puorro remarks in a June 24 release. Earlier this year Candela booked a $2.6 mil. restructuring charge to second quarter earnings to close the Scottsdale facility ("The Gray Sheet" Jan. 26, p. 15). The financial performance of Candela's Boston center "continue to improve," Puorro notes...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.